Wuchterl Donald A. 4

What Happened Donald A. Wuchterl, a director of ABEONA THERAPEUTICS, was granted 37,313 restricted shares on January 26, 2026. The Form 4 reports an acquisition price of $0.00 (typical for compensation awards). The shares are restricted and, per the filing footnote, will vest in full on January 26, 2027. This was an equity award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-01-26 (reported on Form 4 filed 2026-01-27).
• Transaction type/code: Award/Grant (A).
• Shares granted: 37,313; reported acquisition price: $0.00.
• Vesting: All restricted stock will vest on January 26, 2027 (footnote F1).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• No 10b5-1 plan, tax withholding, or 83(b) election is reported in the excerpt; filing appears timely (filed the next day).

Context Restricted stock awards are a form of compensation and typically vest over time; they do not indicate an immediate market buy or sell by the insider. Taxes on these awards are generally addressed at vesting unless an 83(b) election is filed (none reported here). For retail investors, compensation grants are routine for executives and directors and should be weighed alongside other insider transactions and company fundamentals.